CollegiateTimes published an article titled, “Kratom reversal an optimistic sign for changing drug policy.” The article reads in part as follows;
“In an interesting, but positive turn of events, the U.S. Drug Enforcement Agency (DEA) has listened to the outraged voices of the citizens and has temporarily lifted the ban of kratom in the United States. Kratom, a plant native to Southeast Asia and used as a painkiller or safe alternative to prescription or illegal opiates, was previously assumed to be assigned as a Schedule I drug as of Sept. 30 due to an emergency scheduling order.
However, the DEA has surprisingly announced that it has not reached a final decision and is allowing a public discussion period. This is extremely important for recovering addicts who rely on kratom to keep from using heroin, which has increasingly been laced with the even deadlier drug fentanyl. This decision also shows promise for future communication between the public and the DEA, which is especially important in the midst of sporadic marijuana legalization, but also possibly for other incorrectly scheduled drugs such as psychedelics.
The DEA had intended to ban kratom as an, “Emergency scheduling order,” which is a misleading way of saying it did not do its research and made this decision out of fear. Supposedly, a small number of deaths were linked to kratom usage; however, in these rare cases other drugs were also used.
However, this, along with its increasingly widespread usage and association with heroin, seemed like enough reason for the DEA to move to emergency classify it as Schedule I for a minimum of two years.”